BWAY — Brainsway Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1505065 ·
Last close
$9.11
Market Cap
$366.29M
52W High
$17.40
52W Low
$7.14
ADV30
125,325
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 18,146,000 | 14,135,000 | 2,590,000 | 2,222,000 | 125,895,000 | 30,054,000 | 43,657,000 |
| Jun 2026 | 17,107,000 | 12,766,000 | 2,391,000 | 2,710,000 | 121,975,000 | 62,108,000 | 42,786,000 |
| Mar 2026 | 15,531,000 | 11,675,000 | 2,005,000 | 2,290,000 | 116,998,000 | 58,636,000 | 41,201,000 |
| Dec 2025 | 14,545,000 | 11,118,000 | 1,916,000 | 2,933,000 | 112,917,000 | 67,700,000 | 39,696,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$8,105,000
Investing CF
$-11,639,000
Financing CF
$-2,254,000
CapEx
$-3,619,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.24
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-85,806,000
Inventory
$7,310,000
Receivables
$7,032,000
ST Investments
$1,060,000
EBIT TTM
$11,877,000
Pretax Income TTM
$9,677,000
Interest Exp TTM
$2,200,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$60,695,000
EBITDA
$8,483,000
Free Cash Flow
$-6,157,500
Enterprise Value
$484,314,976
Total Cash
$62,108,000
Total Debt
$7,133,000
Shares Out
40,207,981
Trailing EPS
$0.23
Book Value
$2.04
ROE
12.8%
ROA
4.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 52,225,000 | 4,323,000 | 7,633,000 | 112,917,000 | 39,696,000 | 73,221,000 | 18,020,000 |
| Dec 2024 | 41,016,000 | 1,391,000 | 2,921,000 | 94,316,000 | 32,003,000 | 62,313,000 | 10,298,000 |
| Dec 2023 | 31,785,000 | -4,959,000 | -4,197,000 | 62,972,000 | 21,391,000 | 41,581,000 | 1,284,000 |
| Dec 2022 | 27,177,000 | -12,683,000 | -13,349,000 | 64,477,000 | 19,080,000 | 45,397,000 | -9,760,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.51
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $8.98 · call volume: 24 · put volume: 0
Expected Move to 2027-01-15:
±$6.78
(75.45%) —
implied range
$2.20 –
$15.75
· ATM straddle on $10.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CV | CapsoVision, Inc | $356.50M | $6.65 | — |
| CERS | CERUS CORP | $383.71M | $1.90 | — |
| EMBC | Embecta Corp. | $348.46M | $6.15 | — |
| MOBI | Mobia Medical, Inc. | $419.80M | $12.61 | — |
| BRSYF | Brainsway Ltd. | $427.01M | $10.62 | — |
News headlines (Yahoo Finance, 1h cache)
BrainsWay Ltd (BRSYF) (Q3 2026) Earnings Call Highlights: Revenue Jumps 34% as Margins Expand ...
2026-11-10 21:08 · Yahoo
What Brainsway (BWAY) Said on Its Q3 Earnings Call
2026-11-10 17:15 · Yahoo
BrainsWay Reports Third Quarter 2026 Financial Results and Operational Highlights
2026-11-10 12:30 · Yahoo
BrainsWay Announces Strategic Collaboration with Mindful Health Solutions
2026-11-02 12:30 · Yahoo
BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026
2026-10-28 12:00 · Yahoo
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
2026-10-26 11:30 · Yahoo
BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group
2026-10-19 11:30 · Yahoo
BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
2026-10-13 11:30 · Yahoo
BrainsWay’s (BWAY) Growth Streak Just Got Harder To Ignore
2026-09-11 02:56 · Yahoo
Are Options Traders Betting on a Big Move in Brainsway Stock?
2026-09-09 17:58 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.